Elizabeth Marie Thomas

Elizabeth Marie Thomas is a notable inventor based in Lexington, KY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective estrogen receptor-β agonists. Her work has the potential to impact various medical conditions, showcasing her innovative spirit and dedication to improving health outcomes.

Latest Patents

Elizabeth holds one patent titled "Substituted tetralins as selective estrogen receptor-β agonists." This invention relates to novel tetralin ER-β agonist compounds, pharmaceutical compositions thereof, and their use in treating ER-β mediated diseases. These diseases include nocturia, obstructive uropathy, benign prostatic hypertrophy, obesity, dementia, hypertension, incontinence, colon cancer, prostate cancer, infertility, depression, leukemia, inflammatory bowel disease, and arthritis. Her patent reflects her commitment to addressing complex health issues through innovative solutions.

Career Highlights

Elizabeth is currently associated with Eli Lilly and Company, a leading pharmaceutical company known for its research and development in various therapeutic areas. Her role at Eli Lilly allows her to collaborate with other talented professionals and contribute to groundbreaking advancements in medicine.

Collaborations

Some of her notable coworkers include Bryan Hurst Norman and Julian Stanley Kroin. Their collaboration fosters a dynamic environment for innovation and the development of new therapeutic solutions.

Conclusion

Elizabeth Marie Thomas exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and work at Eli Lilly and Company highlight her dedication to improving healthcare and addressing significant medical challenges.

Profile summary based on public USPTO records.